Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study

BACKGROUND: The obesity paradox is a topic of increasing interest in oncology and epidemiology research. Although this phenomenon has been observed in melanoma patients receiving immune checkpoint inhibitors, little is known about its mechanism. We aim to investigate the prognostic value of obesity...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Hyung, Sujin, Lee, Jeeyun, Choi, Sang-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413167/
https://www.ncbi.nlm.nih.gov/pubmed/36002189
http://dx.doi.org/10.1136/jitc-2022-005226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413167/
https://www.ncbi.nlm.nih.gov/pubmed/36002189
http://dx.doi.org/10.1136/jitc-2022-005226

Ejemplares similares